Drug Shortage Report for TEVA-CANDESARTAN

Last updated on 2020-08-21 History
Report ID 102931
Drug Identification Number 02366312
Brand name TEVA-CANDESARTAN
Common or Proper name CANDESARTAN 8MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CANDESARTAN CILEXETIL
Strength(s) 8MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-09
Estimated end date 2020-08-31
Actual end date 2020-08-20
Shortage status Resolved
Updated date 2020-08-21
Company comments Allocating to 100% of our market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-08-21 English Compare
v11 2020-08-20 French Compare
v10 2020-08-20 English Compare
v9 2020-05-14 French Compare
v8 2020-05-14 English Compare
v7 2020-05-08 French Compare
v6 2020-05-08 English Compare
v5 2020-04-23 French Compare
v4 2020-04-23 English Compare
v3 2020-01-10 English Compare
v2 2020-01-09 French Compare
v1 2020-01-09 English Compare